MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$213,192K
Accounts receivable, net
$18,000K
Prepaid expenses and
other current assets
$5,463K
Total current assets
$236,655K
Operating lease
right-of-use assets
$1,469K
Other assets
$1,216K
Property and equipment,
net
$846K
Restricted cash
$107K
Total assets
$240,293K
Total liabilities,
convertible preferred...
$240,293K
Total shareholders'
equity (deficit)
$203,012K
Total liabilities
$37,281K
Accumulated deficit
-$171,809K
Additional paid-in capital
$370,793K
Total current
liabilities
$36,072K
Operating lease
liability, noncurrent
$1,209K
Series a non-voting
convertible preferred...
$4,000K
Ordinary shares, 0.001
par value shares and...
$28K
Accrued expenses and
other current...
$16,344K
Accounts
payable-Nonrelated Party
$9,997K
Deposit liability
$5,000K
Deferred revenue
$4,156K
Operating lease
liability, current
$435K
Related party accounts
payable and other...
$140K
Back
Back
Balance Sheet
source: myfinsight.com
CRESCENT BIOPHARMA, INC. (CBIO)
CRESCENT BIOPHARMA, INC. (CBIO)